Zoetis Inc. Other Restructuring Costs
Zoetis Inc. (ZTS) reported Other Restructuring Costs of -$39.00 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-02-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherRestructuringCosts · last filed 2018-02-15
- Zoetis Inc. other restructuring costs for fiscal 2015 was -$39.00M.
- Zoetis Inc. other restructuring costs for fiscal 2013 was -$24.00M.
| Period end | Other Restructuring Costs 12 month |
|---|---|
| 2015-12-31 | -$39.00M 10-K · filed 2018-02-15 |
| 2013-12-31 | -$24.00M 10-K · filed 2016-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |